Osteoinductive calcium phosphate (CaP) bone grafts have equivalent performance to autografts in repairing critical-size bone defects. The osteoinductive potential of CaP is linked to the size of the surface topographical features. In the present study, two novel biphasic calcium phosphate (BCP) bone grafts were synthesised with either sub-micron-(BCP <µm ) or micron-scale (BCP µm ) needle-shaped surface topography and compared to dimensionally similar tricalcium phosphate (TCP) with grain-shaped surface structures (TCP <µm and TCP µm ). To clarify the possible function of the surface morphology (needle-like vs. grain-like) in initiating bone formation, the four CaP test materials were physicochemically characterised and implanted for 12 weeks in the dorsal muscle of beagles. The sub-micron needle-shaped topography of BCP <µm triggered earlier bone formation (3-6 weeks) as compared to the grain-shaped surface topography of TCP <µm , which formed bone at 6-9 weeks. After 12 weeks, the amount of induced bone formation in both materials was equivalent, based on histomorphometry. The micron-sized needle-shaped surface topography of BCP µm led to limited formation of new bone tissue, whereas its counterpart, TCP µm with grain-shaped surface topography, failed to trigger de novo bone formation. The relative strength of the parameters affecting CaP-driven bone induction was as follows: surface feature size > surface feature morphology > substrate chemistry. BCP materials with needleshaped sub-micron surface topography gave rise to accelerated bone formation and slower rate of resorption than a comparable TCP. These characteristics may be translated to improve bone healing in orthotopic defects.
Introduction
Owing to their similarity to the inorganic component of bone, their bioactivity, biocompatibility and osteoconductivity, calcium phosphate (CaP) materials are used clinically as bone void fillers (Habraken et al., 2016; Samavedi et al., 2013) . However, because they lack osteoinductivity, their efficacy is perceived as being lower than that of the gold standard bone graft, autologous bone, in repairing critical-size bone defects (Acharya et al., 2008 ; Miyazaki et al., 2009 ).
Unless osteogenic agents are added to the graft material pre-implantation, osteoinduction of CaP bone grafts on their own is not reported until the beginning of the 1990s. Since then, initiation of bone formation by various CaP bone grafts with specific physicochemical properties is observed in studies of non-skeletal defect sites (e.g. subcutis and muscle) (Pollick, et al., 1995; Ripamonti, 1991; Yamasaki and Sakai, 1992; Zhang et al., 1991) .
Studies comparing osteoinductive versus nonosteoinductive CaP in orthotopic skeletal sites www.ecmjournal.org demonstrate the benefits of osteoinductivity in bone regeneration (Duan et al., 2016) . Osteoinductive CaP bone grafts not only trigger ectopic bone formation, but also enhance orthotopic bone formation by inducing osteogenic differentiation of mesenchymal stem cells (MSCs) (Davison et al., 2014a) . One such osteoinductive CaP bone graft substitute has equivalent performance to an autograft, considered to be the gold standard bone graft, in repairing critical-size bone defects (Yuan et al., 2010) . Having established a link between osteoinductivity and boneforming potential in orthotopic sites, researchers are focused on developing osteoinductive CaP bone grafts that can trigger high quality bone formation as early as possible after implantation.
Osteoinduction by CaP bone grafts is materialdependent and the osteoinductive potential varies with their physicochemical properties (Barradas et al., 2011; LeGeros et al., 2008) , such as chemistry [i.e. the ratio hydroxyapatite (HA)/tricalcium phosphate (TCP)] (Habibovic et al., 2006) , microporosity (i.e. the percentage of pores < 10 µm) (Barba et al., 2017; Chan et al., 2012) and surface architecture and geometry (Dalby et al., 2007; Davison et al., 2014a; Habibovic et al., 2005) . Among those, the presence of a microporous structure is essential. Yuan et al. (1999) demonstrate that microporous HA induces ectopic bone formation, while a non-microporous HA does not. Furthermore, reducing the size of features on a microporous surface is critical for endowing CaP materials with osteoinductive properties. For instance, sub-micron-scale surface structured TCP can induce ectopic bone formation, while an equivalent but micron-scale surface structured alternative fails (Davison et al., 2014a; Duan et al., 2017) . The influence of surface feature size is also seen in biphasic calcium phosphates (BCP), where materials with smaller grain crystals initiate ectopic bone formation, while materials with larger structures do not (Davison et al., 2015; Habibovic et al., 2005) . These studies confirm that the size of surface features plays an important role in initiating bone formation by CaP materials in ectopic defect sites.
Currently, there is still limited knowledge as to the molecular mechanism underlying surface-topography-induced differentiation of MSCs. Geometrical features can enhance the actomyosin contractility and facilitate osteogenesis by enhancement of c-Jun N-terminal kinase and activation of the extracellular-related kinase in conjunction with elevated wingless-type (Wnt) signalling (Kilian et al., 2010) . Furthermore, Zhang et al. (2017) report that the surface topography of CaPs can tune MSCs with respect to morphology, primary cilia length and transforming growth factor beta receptor (TGFβR) recruitment to the cilium, all of which are associated with osteogenic differentiation in vitro and bone formation in vivo.
Next to the size of features on the surface structure, the morphology is another characteristic of the surface topography which can evoke specific cellular responses in vitro (Agarwal et al., 2013; Dasgupta et al., 2014; Kolha et al., 2013; Metavarayuth et al., 2016; Ross et al., 2012) . Kolhar et al. (2013) show that rod-shaped nanoparticles have higher affinity for endothelial cells in in vitro and in vivo as compared with their spherical counterparts. Similarly, Agarwal et al. (2013) report that elongated nanoparticles induce more cell adhesion and facilitate the multivalent interaction between cells and surfaces, compared to spherical nanoparticles. Dasgupta and co-workers observe that the elongated particles with higher aspect ratio induce extensive cellular uptake as compared to spherical particles with an average diameter (Dasgupta et al., 2014) . Furthermore, in vitro studies indicate that surface morphology changes modulate adhesion, cytokine release and gene expression of osteogenic cells (Metavarayuth et al., 2016; Ross et al., 2012) . Based on these data, the working hypothesis was that, besides the surface feature size, the morphology of the surface structure might play a crucial role in triggering bone formation in CaP materials.
The relative influence of surface feature size, surface morphology and substrate chemistry on osteoinductivity of CaP bone grafts was investigated by employing a hydrothermal treatment to obtain two needle-shaped surface structures on BCP at submicron-and micron-scale and by comparing their in vivo bone-forming potential to sub-micron and micron grain-shaped TCP counterparts.
Materials and Methods
Engineering the surface morphology S u b -m i c r o n g r a i n -l i k e -s u r f a c e -s t r u c t u r e d osteoinductive CaP (TCP <µm , positive control) and micron grain-like-surface-structured nonosteoinductive CaP (TCP µm , negative control) were prepared in granular format (1-2 mm) as previously described (Davison et al., 2014a; Duan et al., 2016) .
The two novel CaP materials were manufactured by Kuros Biosciences B.V. (Bilthoven, the Netherlands). Briefly, BCP powder was synthesised using a wet precipitation of apatite powder, followed by foaming with H 2 O 2 (1 % in distilled water; Merck) and sintering for 6 h at either 1125 °C or 1200 °C to obtain BCP plaques. After crushing the plaques and sieving, BCP granules (1-2 mm) were prepared and autoclaved at 135 °C for 99 min, to form novel CaP materials with either sub-micron (BCP <µm ) or micronscale (BCP µm ) surface topography. All materials were sterilised with gamma irradiation (dose 25-40 kGy, Isotron Nederland B.V., Ede, the Netherlands) prior to use.
Physicochemical characterisation of CaP materials
The chemical composition of the CaP materials (n = 1 per material) was identified by X-ray diffraction
Influence of surface morphology on bone formation (XRD; Miniflex II, Rigaku, Tokyo, Japan) using a scanning range of 25-45°, a step size of 0.01° and a scanning rate of 1°/min. The amount of HA phase was determined by using an internal calibration system. The surface structure of the CaP materials was analysed using a scanning electron microscope (SEM; JEOL JSM-5600, JEOL Ltd, Tokyo, Japan). The surface grain size (i.e. the vertical length crossing the centre of each grain) and the shortest axis of the needles were measured using an AxioVision LE (Carl Zeiss MicroImaging, Inc.) for at least 100 random grains or needles visualised from 10 SEM images (magnification: 5000×).
The microporosity and the specific surface area were determined by mercury intrusion porosimetry (n = 1 per material; Micromeritics Autopore 9600 Mercury Porosimeter, Norcross, GA, USA) with a mercury temperature of 18.36 °C and contact angle of (I) 130.00°, (E) 130.00°.
In vitro assay: dissolution rate
Calcium ion release was evaluated by soaking 0.5 mL of CaP granules (n = 5 per material) in 100 mL of simulated physiological saline [SPS; 0.8 % NaCl, 50 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), 0.4 mM NaN 3 ; 37 °C; pH = 7.3] solution for 200 min. While carefully stirring at 150 ×g to avoid the contact between the stirring bar and granules, the calcium ion concentration in SPS was recorded every minute using a calcium electrode (Metrohm, Herisau, Switzerland).
In vitro assay: protein adsorption
Protein adsorption was measured for two types of protein solutions. Sterile CaP granules (0.2 mL, n = 5 per material) were added to 2 mL of 1 % volume foetal bovine serum (FBS) solution or 2 mL of 400 µg/mL bovine serum albumin (BSA) solution at 37 °C and 5 % CO 2 for 1 week. Protein adsorption was measured after 12 h, 1, 4 and 7 d using a micro BCA assay kit (Micro BCA Protein Assay Kit, ThermoFisher Scientific) and a spectrophotometer with an absorbance filter of 595 nm. The amount of protein adsorbed by the samples (expressed in mg/ mL for FBS and in µg/mL for BSA) was estimated using internal calibration protein curves and reported per 1 mL, which corresponded to the volume of material implanted in vivo.
In vivo assay: intramuscular implantation
All surgeries were performed following ethical approval by the local animal care committee (i.e. To evaluate their osteoinductive potential, the four CaP materials (n = 8 for each group) were implanted in the dorsal muscles of healthy beagles (n = 8, 2-4 years, 10-15 kg), for 12 weeks, as described previously (Davison et al., 2014a; Duan et al., 2016) . Briefly, under general anaesthesia by intravenous injection of sodium pentobarbital (30 mg/kg body weight) and in sterile conditions, 1 mL of each test group was implanted into paraspinal muscle pockets created by blunt dissection. The pockets were kept isolated from each other to prevent contact between the samples. Subsequently, the muscle wound was closed with non-resorbable sutures and the skin incisions were closed layer by layer. Following the surgeries, buprenorphine (0.1 mg per animal) was injected intramuscularly for 2 d to relieve pain, while penicillin (40 mg/kg) was injected intramuscularly for 3 consecutive days to prevent infection. Animals were allowed to undertake full activity and received a normal diet immediately after surgery. To determine the time of bone formation onset, three fluorescent histological labels were utilised to indicate osteogenesis at: 1-3 weeks (calcein; green staining); 3-6 weeks (xylenol orange; red staining); 6-9 weeks (tetracycline; yellow staining). Fluorochromes were intravenously injected at 3 weeks (calcein, Sigma-Aldrich; 5 mg/mL, 2 % NaHCO 3 solution, pH = 7.41, injection volume: 2 mL/kg body mass), 6 weeks (xylenol orange, Sigma-Aldrich; 50 mg/mL, 1 % NaHCO 3 solution, pH = 7.38, injection volume: 2 mL/kg body mass) and 9 weeks (tetracycline, Sigma-Aldrich; 10 mg/mL, 0.9 % NaCl solution, pH = 7.41, injection volume: 2 mL/kg body mass) after implantation.
In vivo assay: implants harvest and histological processing 12 weeks after implantation, animals were sacrificed by intravenous injection of an excessive dose of sodium pentobarbital and the implants were harvested with their surrounding soft tissue, trimmed and fixed at 4 °C in 4 % buffered formaldehyde solution (pH = 7.4) for at least 1 week. Following fixation, the samples were dehydrated using a series of gradient ethanol solutions and embedded in methyl methacrylate (MMA, K-plast, LTI, Bilthoven, the Netherlands). Consecutive histological sections (10-20 µm) of non-decalcified samples were obtained by sectioning the whole samples using a diamond saw blade microtome (SP-1600, Leica). The sections were alternately not stained and stained with 1 % methylene blue (Sigma-Aldrich) and 0.3 % basic fuchsin (Sigma-Aldrich) after etching with acidic ethanol (Merck). The stained sections were analysed by light microscopy (Nikon Eclipse E200, Tokyo, Japan) and histomorphometry. Non-stained sections were analysed by fluorescence microscopy using a FITC Texas Red filter (Nikon) at bandpass mirror wavelengths of 510-555 nm and 585-665 nm.
In vivo assay: histology and histomorphometry
Stained histological sections were scanned with a slide scanner (Dimage Scan Elite 5400II, Konica Minolta Histomorphometric analysis was performed using Adobe Photoshop Elements 4.0 software (CS5, v12, Adobe Systems Benelux BV) as follows. First, the area encompassing the whole sample was selected as a region of interest (ROI) and the corresponding number of pixels was read as ROI. Then, the bone tissue and residual material areas were pseudo-coloured and their respective pixels were counted as B (= bone) and Me (= residual material), respectively. The percentage of bone in the available space was determined as B % = B × 100/ (ROI − Me), while the percentage of residual material was calculated as Me % = Me × 100/ROI. The percent area of material resorbed (M %) was calculated as M % = (M0 − Me) × 100/M0, where M0 was the mean pixel area of similarly embedded, sectioned and pseudo-coloured materials (1 mL, n = 8) that were not implanted.
Unstained histological sections were observed using fluorescence microscopy (Nikon Eclipse E600, Japan; camera Nikon FDX-35) to determine the time of onset of bone formation and material biomineralisation. The incidence (for total animals operated) of three fluorescent labels in the explants was recorded, while the number of xylenol orange staining spots (6 weeks, red colour) in the samples was counted. A quantitative index (X fluor ), which indicated early bone formation (< 6 weeks), was calculated as the ratio between the total spots counted in all animals and the incidence of fluorescent labels.
Statistical analysis
Normality of the data was assessed using the ShapiroWilk test (p > 0.05 for normally distributed data) and statistical comparisons were carried out by one-way ANOVA and Tukey's post hoc tests, where a p < 0.05 was considered statistically significant.
Results
Physicochemical characterisation of materials X-ray diffraction analysis confirmed that the two novel CaP materials were BCP (i.e. BCP <µm : 25 % HA/75 % TCP; BCP µm : 22 % HA/78 % TCP), while both the positive and the negative controls were pure β-TCP (Fig. 1a and Table 1 ).
SEM imaging revealed that the two novel CaP materials had either sub-micron (median, 0.60 µm) or micron-scale needles (median, 1.52 µm) on their surface, comprising an epitaxial polygon surface (Fig. 2a and Table 1 ).
In vitro assays: protein adsorption BCP <µm and TCP <µm adsorbed similar amount of proteins from BSA but TCP <µm absorbed more protein from FBS (Fig. 2b,c) . Both TCP µm and BCP µm absorbed significantly less protein from BSA and FBS than their sub-micron counterpart test materials (Table 1) .
Histology and histomorphometry
After 12 weeks of intramuscular implantation, all explants were encapsulated by a thin layer of connective tissue, which also infiltrated the CaP materials. De novo bone formation was observed in 8 out of 8 BCP <µm and TCP <µm (positive control) explants, 7 out of 8 BCP µm explants and 0 out of 8 TCP µm (negative control) explants (Fig. 3a , Table 2 ). Osteoids with a seam of cuboidal osteoblasts lying on their outer surface as well as osteocytes entrapped in lacunae of lamellar and woven bone were clearly observed in BCP <µm , TCP <µm and BCP µm explants (Fig.  3b,c) . In addition, multinucleated osteoclast-like cells phagocytising small fragments of CaP were localised on the surface of the test CaP material for BCP <µm (22 ± 7 cells/mm 2 ) and TCP <µm (14 ± 6 cells/ mm 2 ) groups. In contrast, the multinucleated osteoclast-like cells were sporadically present in BCP µm (4 ± 3 cells/mm 2 ) and scarcely present in any of the non-osteoinductive TCP µm (0 cells/mm 2 ) (Fig. 4) . More condensed collagen fibrils, bone marrow and blood vessels were observed in BCP <µm and TCP <µm implants, which were less compact in BCP µm . Looser connective tissue, with very limited presence of blood vessels, was detected in TCP µm . 
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Under fluorescent microscopy ( Fig. 5 , Table 2 ), xylenol orange was detected in 5 out of 8 BCP <µm and in 2 out of 8 of TCP <µm explants. Calcein and tetracycline were observed in all the BCP <µm and TCP <µm explants. Only calcein was found in BCP µm explants and no fluorescent signal was measured in any of the TCP µm explants. Xylenol orange was detected in the bone inside the BCP <µm implants, indicating that the marked bone formed between 3 and 6 weeks post-implantation. Whereas, tetracycline was the predominant fluorophore observed in the bone formed in TCP <µm , revealing that it formed between 6 and 9 weeks. No xylenol orange or tetracycline fluorophores were detected in BCP µm , indicating no bone formation in these defects after 9 weeks post-implantation. These qualitative observations were corroborated by the quantitative data. In fact, the X fluor index and the xylenol orange incidence (Table 2) indicated that much more bone was formed between week 3 and week 6 in BCP <µm as compared to the positive control (TCP <µm ). In sharp contrast, BCP µm and TCP µm showed no xylenol orange fluorescence (Table 2) .
BCP <µm led to faster bone formation but, by the time of sacrifice at 12 weeks, BCP <µm and the positive control, TCP <µm , led to similar amounts of bone tissue, as measured by histomorphometry: 24.5 ± 4.3 % and 23.9 ± 6.3 %, respectively, followed by BCP µm (2.1 ± 1.7 %). No bone formed in TCP µm (Fig. 6a) . In addition, the percentage area of resorbed material (by histomorphometry) profoundly varied among the four materials: TCP <µm underwent the most material resorption (53.8 ± 5.7 %), followed by BCP <µm (28.1 ± 4.1 %), BCP µm (9.3 ± 2.4 %) and TCP µm (4.7 ± 2.1 %) (Fig. 6b) .
Discussion
A hydrothermal treatment was employed to promote the growth of a layer of epitaxial crystals on the surface of BCP materials, leading to a novel needle-shaped surface topography. By adjusting the sintering temperature (i.e. 1125 °C or 1200 °C) of the BCP materials, needle-like crystals at either the sub-micron or micron-scale were achieved (Fig. 1) . In vivo, the novel CaP with sub-micron needle-shaped topography (BCP <µm ) triggered earlier bone formation (3-6 weeks) as compared to TCP with a sub-micron grain-shaped surface topography (TCP <µm ), which mainly formed bone at 6-9 weeks (Fig. 5) . By 12 weeks post-implantation, the amount of bone formed by the positive control, TCP <µm , was equivalent to the amount formed by the novel needle-like surface topography of BCP <µm (Fig. 6a) . Similarly, BCP µm with a micron-scale needle-shaped surface topography underwent in vivo biomineralisation and gave rise to ectopic bone formation, while its counterpart, TCP µm , with micron-scaled grain-like crystals did not (Fig. 5,6a ).
In agreement with previous reports, the size of the surface structure greatly affected the osteoinductive potential of CaP materials (Davison et al., 2014a; Duan et al., 2016; Duan et al., 2017; Habibovic et al., 2005; Yuan et al., 2010; meeting abstract: Duan et al., ORS 2018 Annual Meeting: 0056) . As expected, inductive bone formation occurred in larger amounts for the sub-micron surface structured BCP <µm and TCP <µm grafts but very limited bone formed in BCP µm and no bone formed in TCP µm , both having a micronscale surface topography (Fig. 3, 4, 5 and 6 ). The strength of the observed effect suggested that the Bone area in available space (B %) 24.5 ± 4.3 23.9 ± 6.3 2.1 ± 1.7 0
Material resorption (%) 28.1 ± 4.1 53.8 ± 5.7 9.3 ± 2.4 4.7 ± 2.1 www.ecmjournal.org scale of topography influenced osteoinductivity independently of chemistry and surface morphology. Based on the available data for grain size, surface area and protein adsorption for BCP <µm and TCP <µm versus BCP µm and TCP µm , this could either be due to a direct or an indirect effect of the smaller surface feature size on bone formation. Could the specific surface topography exert a direct effect on bone formation by affecting attached cells? In the absence of chemical factors, surface topographies ranging from nano-to micronscale evoke specific cell attachment, orientation, proliferation and guide cell differentiation towards various lineages (Abagnale et al., 2015; Dupont et al., 2011; Kolind et al., 2014; Mitragotr and Lahann, 2009; Oh et al., 2009; Phadke et al.,2013) . At the micron-scale, surface structure enhances adipogenic differentiation of MSCs, while sub-micron-scaled surface structures favours osteogenic differentiation (Abagnale et al., 2015; Davison et al., 2014a; Duan et al., 2016) . Submicron surface topographies can preferentially direct early wound healing toward the bone-forming pathway by influencing macrophage polarisation (Italiani and Boraschi, 2014; Loi et al., 2016; Spiller et al., 2015; meeting abstract: Duan et al., ORS 2018 Annual Meeting: 0056). The role of macrophages as either mediators of a pro-inflammatory response or mediating a wound-healing and angiogenic response is well understood (Italiani and Boraschi, 2014) . The key to successful bone healing, that is to promote osteogenesis and avoid the formation of scar tissue, is to tip the balance of wound healing toward the M2, or deactivated, macrophage response following an initial phase of inflammation (Loi et al., 2016; Spiller et al., 2015) . CaP materials with a sub-micron surface topography direct the transition of macrophages to the M2 phenotype, as shown by the larger production of TGF-β and chemokine (C-C motif) ligand 18 (CCL18) from cells cultured on CaP with sub-micron surface structures (meeting abstract: Duan et al., ORS 2018 Annual Meeting: 0056) . At the same time, CaP materials with micron surface topography display more M1 macrophages formation, as indicated by an enhanced TNF-α and IL-1β secretion (meeting abstract: Duan et al., ORS 2018 Annual Meeting: 0056) . The conditioned media harvested from THP-1 cells cultured on CaP with submicron surface topography enhance tube formation by human umbilical vein endothelial cells (HUVECs) in vitro. Furthermore, sub-micron surface topography enhances angiogenesis and triggers bone formation in ectopic defect sites (meeting abstract: Duan et al., ORS 2018 Annual Meeting: 0056) . Whether the specific surface topography could exert an indirect effect on bone formation was considered. Protein adsorption is often suggested as crucial in inductive bone formation (Ariizumi et al., 2013; Bolander et al., 2016; Webster et al., 2001) , where osteoinduction of CaP materials is thought to be a secondary response following the adsorption of growth factors/cytokines from body fluids in vivo (Groot et al., 1998; Jin et al., 2009; Reddi et al., 2000) . Since the function of growth factors/cytokines is dosedependent (Bonilla-Claudio et al., 2012; Hunziker et al., 2016) , theoretically the more proteins concentrated in the implants should lead to higher osteoinductive potential. In the present study, TCP <µm adsorbed significantly more proteins from FBS per implant than BCP <µm (Fig. 2b,c and Table 1 ), while the latter triggered earlier bone formation than the former. Similarly, BCP µm adsorbed similar or little more proteins than TCP µm , but while the former triggered bone formation, the latter did not (Fig. 2b,c and Table  1 ). Therefore, it was concluded that the initiation and enhancement of inductive bone formation in BCP <µm and TCP <µm was less likely to be due to a larger surface area (and associated increased protein adsorption) but, more likely, instructed by the possible physical cues created by the smaller features in the surface topography.
It is important to consider which of the other effects of chemistry and surface feature morphology was most dominant in driving earlier bone formation in ectopic defects, as observed for BCP <µm (3-6 weeks) when compared to TCP <µm (6-9 weeks). Firstly, BCP <µm consisted of 25 % HA/75 % β-TCP, while TCP <µm was phase-pure β-TCP. Although the role of chemical composition appears not to be an essential material factor to trigger inductive bone formation in CaP materials (Duan et al., 2017) , it is generally thought that a higher content of TCP can affect the dissolution of CaP and, thus, the ion release (e.g. calcium and phosphate) from its surface. In turn, this increased ion release may enhance inductive bone formation (Chai et al., 2012; Habibovic et al., 2006; Nakamura et al., 2010; Shih et al., 2014; Yuan et al., 2006a; Yuan et al., 2006b) . However, in the present study, BCP <µm released less calcium ions in vitro than TCP <µm (Fig. 2a ) and resorbed at a slower rate than TCP <µm in vivo (Fig.  6b) . Therefore, the earlier trigger or enhancement of bone formation observed in the present study for BCP <µm seemed not to be attributed to the rate of calcium ion release.
Both BCP test materials had in vivo resorption rates between those observed for TCP <µm and TCP µm (Fig.  6b) , contrary to the general view that a higher TCP content would lead to a faster resorption. BCP µm had the lowest dissolution in vitro (Fig. 2a) but a faster rate of resorption as compared to TCP µm in vivo, indicating that cell-mediated resorption played a major role in the in vivo resorption of the BCP test articles. This was further corroborated by the histological analysis (Fig.  3b,c) , in which multinucleated osteoclast-like cells were observed on the materials' surface. Whether chemistry could dictate the mechanism of resorption and indirectly drive earlier bone formation in BCP <µm was analysed, resulting not to be a dominant factor, since abundant resorption by multi-nucleated giant cells was also observed by histological analysis in TCP <µm (Fig. 3c) . The slower resorption observed for BCP µm as compared to BCP <µm corroborated the findings of Davison et al. (2014b) , according to which CaP ceramic with sub-micron-scaled surface structures favoured the formation of osteoclasts from mononuclear cells and facilitated material resorption as compared to its micron-scale structured counterpart. Therefore, according to the present study, if the presence of multinucleated osteoclastlike cells was a driver for osteoinductive potential, the size of the surface topography feature was more likely to be the dominant factor than the chemistry.
BCP and TCP families contained a different level of microporosity (Table 1) . Microporosity determines the osteoinductive potential of CaP materials because it creates an ideal microenvironment for protein adsorption and/or cell attachment, differentiation and proliferation (Barba et al., 2017; Chan et al., 2012; Davison et al., 2014a; Duan et al., 2016; Duan et al., 2017; Yuan et al., 2010) , where higher microporosity leads to higher osteoinductive potential (Chan et al., 2012) . Since lower microporosity was detected in the BCP than in the TCP family, the trigger of earlier inductive bone formation observed in BCP <µm was not likely to be linked to microporosity.
Based on the study data and the supporting literature, the most dominant secondary factor (after surface feature size) for CaP driven osteoinductivity is the surface feature morphology of the substrate. In the present study, needle-shaped surface features gave rise to earlier bone formation than grainshaped surfaces. As chemistry is still likely to have a certain level of influence on osteoinductivity, the strength of effect was proposed to be as follows: surface feature size > surface feature morphology > substrate chemistry. The improved bone formation outcomes for BCP <µm and BCP µm in this intramuscular model indicated that they had higher osteoinductive potential than TCP <µm and TCP µm, respectively. Previous studies show that osteoinductive materials facilitate bone regeneration in orthotopic skeletal sites as compared to non-osteoinductive materials (Duan et al., 2016; Yuan et al., 2010) and that a higher osteoinductive potential correlates with faster bone repair in orthotopic defects (Yuan et al., 2006a) . Therefore, of all the articles tested in the study, BCP <µm may be expected to have good bone regeneration potential in clinical applications.
Using the current settings, the superiority of BCP <µm to the other 3 materials was demonstrated. However, besides the histological and histomorphometrical R Duan et al. Influence of surface morphology on bone formation data, more analyses, such as quantitative µCT, biochemical assays of bone-forming signals and immunohistostaining of bone markers, would make the conclusion stronger. Fluorescent labelling was used to monitor the onset of bone formation at different time points, without the need to include more animals in the study. Another approach could have been to use animal cohorts at each time point, which would allow for a more precise analysis and include bone quantity assessment at each time point. Finally, a clinically relevant animal study (i.e. orthotopic implantation) would be required to more accurately predict the potential clinical efficacy of these materials.
Conclusions
Evaluation of ectopic bone formation by two novel CaP materials with a needle-like surface topography showed that they could give rise to earlier and accelerated bone formation as compared to their counterparts with grain-like surface structures. Our data suggested that the relative strength of effect on osteoinductive potential was as follows: surface feature size > surface feature morphology > substrate chemistry. Of all the materials tested, BCP <µm with a needle-shaped surface topography was expected to have the best bone regeneration potential in clinical applications, although the performance of this material still needs to be evaluated in an orthotopic implantation site.
